Worth Venture Partners’s Bionano Genomics, Inc. Warrant BNGOW Stock Holding History

Worth Venture Partners’s Portfolio BNGOW Stock Details BNGOW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-88,446	Closed	-$65K	–	122
2019 Q2	$65K	Hold	88,446	–	–	0.04%	81
2019 Q1	$112K	Buy	+88,446	New	+$141K	0.06%	70

Other funds holding BNGOW

MIM

Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Worth Venture Partners's BNGOW Position: Q3 2019 in Review

Worth Venture Partners sold out of Bionano Genomics, Inc. Warrant (BNGOW) in Q3 2019, closing a stake of 88,446 shares — an estimated $65K sold.

Worth Venture Partners first reported a position in BNGOW in Q1 2019 and held it in 2 quarters. The position peaked at $112K in Q1 2019. 3 funds tracked by Wall St. Rank hold BNGOW as of Q3 2019.

Worth Venture Partners reported no remaining Bionano Genomics, Inc. Warrant position as of Q3 2019 after selling out during the quarter.
Worth Venture Partners sold 88,446 Bionano Genomics, Inc. Warrant shares in Q3 2019, an estimated $65K.
Worth Venture Partners first reported a position in Bionano Genomics, Inc. Warrant in Q1 2019 and held it in 2 quarters.
Worth Venture Partners's Bionano Genomics, Inc. Warrant position peaked at $112K in Q1 2019.
3 funds tracked by Wall St. Rank held Bionano Genomics, Inc. Warrant as of Q3 2019.

Based on Worth Venture Partners's 13F filing for Q3 2019, filed 12 Nov 2019.